Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;119(2):200-207.
doi: 10.1002/jso.25316. Epub 2018 Nov 27.

Current management of regional lymph nodes in patients with melanoma

Edmund K Bartlett  1
Affiliations
Review

Current management of regional lymph nodes in patients with melanoma

Edmund K Bartlett. J Surg Oncol. 2019 Jan.

Abstract

The publication of recent randomized trials has prompted a significant shift in both our understanding and the management of patients with melanoma. Here, the current management of the regional lymph nodes in patients with melanoma is discussed. This review focuses on selection for sentinel lymph node biopsy, management of the positive sentinel node, management of the clinically positive node, and the controversy over the therapeutic value of early nodal intervention.

Keywords: Completion lymph node dissection (CLND); melanoma; sentinel lymph node (SLN); sentinel lymph node biopsy (SLNB); stage III melanoma.

PubMed Disclaimer

Conflict of interest statement

I have no conflicts of interest or relevant financial affiliations to disclose.

Figures

Figure 1.
Figure 1.. The various scenarios of metastatic progression in melanoma.
The displayed percentages are an estimation of all patients with intermediate thickness melanoma who fall into the indicated category. Estimates are based upon the long-term results of MSLT-1, which demonstrated a 19.5% recurrence rate in observed patients and 21.9% in patients undergoing SLN biopsy. In patients undergoing a SLN biopsy, a nodal metastasis incidence of approximately 20% is the sum of those detected by SLN biopsy and nodal recurrences after a false-negative SLN biopsy. Purple dots denote melanoma metastases.
See this image and copyright information in PMC

Comment in

References

    1. Faries MB, Thompson JF, Cochran AJ, et al. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017;376(23):2211–2222. - PMC - PubMed
    1. Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757–767. - PubMed
    1. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. - PMC - PubMed
    1. Eggermont AM. Adjuvant ipilimumab in stage III melanoma: New landscape, new questions. Eur J Cancer. 2016;69:39–42. - PubMed
    1. Long GV, Hauschild A, Santinami M, et al. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. N Engl J Med. 2017;377(19):1813–1823. - PubMed